EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Hospitalization, ICU admission, and mortality among diabetic patients with inflammatory bowel disease receiving SGLT-2 inhibitors: a retrospective cohort study from the global collaborative network

Omar Abdelhalim iD, Mohammed Y Youssef iD, Sawsan Al-Lababidi iD, Mohamed H Eldesouki iD, Ahmed Mohamed iD, Mohammed Abusuliman iD, Mahmoud Nassar iD, Mohammad Abushanab, Ahmed Salem iD, Hassan Shaheen, Ahmed Aref iD, Khaled M Elhusseiny iD und 3 weitere

Annals of Translational Medicine · 2026-06 · 14 (3) · 32-32

DOI: 10.21037/atm-2026-0131 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Annals of Translational Medicine, 2026-06. Verfasst von Omar Abdelhalim und 14 weiteren Autor:innen. Beteiligte Einrichtung: Icahn School of Medicine at Mount Sinai, Queens Hospital Center, New York, NY, USA. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

IBD-related complicationsSodium-glucose co-transporter-2 inhibitors (SGLT2 inhibitors)diabetes mellitusinflammatory bowel disease (IBD)

Autor:innen und Institutionen

  • Icahn School of Medicine at Mount Sinai, Queens Hospital Center, New York, NY, USA.
  • Hunt Regional Medical Center, Greenville, TX, USA.
  • New York Medical College at St. Michael's Medical Center, Newark, NJ, USA.
  • Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Department of Internal Medicine, Henry Ford Hospital, Detroit, MI, USA.
  • Division of Endocrinology and Diabetes, Larner College of Medicine, University of Vermont, Burlington, VT, USA.

ORCID-Profile: Omar Abdelhalim, Mohammed Y Youssef, Sawsan Al-Lababidi, Mohamed H Eldesouki, Ahmed Mohamed, Mohammed Abusuliman, Mahmoud Nassar, Ahmed Salem, Ahmed Aref, Khaled M Elhusseiny, Chloe Lahoud, Zara Bhutta, Hazem Abosheaishaa

Zitieren

APA

Abdelhalim, O., Youssef, M. Y., Al-Lababidi, S., Eldesouki, M. H., Mohamed, A., Abusuliman, M., Nassar, M., Abushanab, M., Salem, A., Shaheen, H., Aref, A., Elhusseiny, K. M., Lahoud, C., Bhutta, Z., & Abosheaishaa, H. (2026). Hospitalization, ICU admission, and mortality among diabetic patients with inflammatory bowel disease receiving SGLT-2 inhibitors: a retrospective cohort study from the global collaborative network. Annals of Translational Medicine, 14(3), 32-32. https://doi.org/10.21037/atm-2026-0131

Vancouver

Abdelhalim O, Youssef MY, Al-Lababidi S, Eldesouki MH, Mohamed A, Abusuliman M, et al. Hospitalization, ICU admission, and mortality among diabetic patients with inflammatory bowel disease receiving SGLT-2 inhibitors: a retrospective cohort study from the global collaborative network. Annals of Translational Medicine. 2026;14(3):32-32. doi:10.21037/atm-2026-0131

BibTeX
@article{Abdelhalim2026,
  author = {Abdelhalim, Omar and Youssef, Mohammed Y and Al-Lababidi, Sawsan and Eldesouki, Mohamed H and Mohamed, Ahmed and Abusuliman, Mohammed and Nassar, Mahmoud and Abushanab, Mohammad and Salem, Ahmed and Shaheen, Hassan and Aref, Ahmed and Elhusseiny, Khaled M and Lahoud, Chloe and Bhutta, Zara and Abosheaishaa, Hazem},
  title = {Hospitalization, ICU admission, and mortality among diabetic patients with inflammatory bowel disease receiving SGLT-2 inhibitors: a retrospective cohort study from the global collaborative network},
  journal = {Annals of Translational Medicine},
  year = {2026},
  volume = {14},
  number = {3},
  pages = {32--32},
  doi = {10.21037/atm-2026-0131}
}
Kostenlos starten →